Skip to content
Roboearth – Lifestyle
Author:
Biodexa Pharmaceuticals PLC
Preliminary Results for the Year Ended 31 December 2025
March 26, 2026
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
March 23, 2026
ADR Ratio Change
March 18, 2026
←
Previous Page
1
2